Table 1 Sociodemographic and clinical characteristics of TLE patients
From: Mapping connectivity fingerprints for presurgical evaluation of temporal lobe epilepsy
TLE Patients | Seizure Free | Non-Seizure Free | p-value | Healthy participants | ||
|---|---|---|---|---|---|---|
N | 30 | 14 | 16 | 18 | ||
Age | 49.8 ± 11.1 | 50.7 ± 10.9 | 48.9 ± 11.6 | n.s. | 49.50 ± 11.92 | |
Sex(f) | 17(56.7%) | 9(52.9%) | 8(47.1%) | n.s. | 11 (61%) | |
Left TLE | 15(50%) | 7(46.7%) | 8(53.3%) | n.s. | ||
Age onset seizure | 15.2 ± 11.6 | 11.7 ± 10.1 | 18.3 ± 12.3 | n.s. | ||
Duration of epilepsy | 27.4 ± 15.4 | 32.7 ± 13.9 | 22.7 ± 15.5 | n.s. | ||
Febrile seizures | 6(20%) | 2(33.3%) | 4(66.7%) | n.s. | ||
Secondary generalisation | 22(75.9%) | 10(45.5%) | 12(54.5%) | n.s. | ||
ILAE Outcome [21] | 1 | 14 (46.6%) | ||||
2 | 3(10%) | |||||
3 | 9(30%) | |||||
4 | 2(6.6%) | |||||
5 | 2(6.6%) | |||||
6 | – | |||||
Lesion MRI | 25 (83.3%) | 13(53%) | 12(48%) | n.s. | ||
Pathology | HS | 21(70%) | 11(52.4%) | 10(47.6%) | n.s | |
Tumor | 1(3.3%) | 1(100%) | – | |||
Heterotropia | 1(3.3%) | 1(100%) | – | |||
Normal | 5(16.7%) | – | 5 (100%) | |||
Dual (HS + cavernoma/ tumor) | 2(6.7%) | 1(50%) | 1(50%) | |||